In prostate cancer, androgen deprivation increases ANGPTL2 cancer tissue levels leading in turn to androgen-indipendent and malignant behavior of prostatic cancer cells through an autocrine and/or paracrine manner via integrin α5β1 receptor. The gene discussed is ANGPTL2; the disease is cancer.